|
Market Closed -
OTC Markets
17:00:08 24/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 15.75 USD | -3.26% |
|
-.--% | +162.50% |
| 09-28 | Genfit S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 09-15 | French and Benelux stocks-Factors to watch on September 15 | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 74.31B | |||||
| 56.95B | |||||
| 48.3B | |||||
| 44.51B | - | - | - | - | - |
| 43.8B |
- Stock Market
- Stocks
- GNFT Stock
- GNFT.F Stock
- Charts GENFIT
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
